Vendor review
Lipeptides reviews
Lipeptides reviews from 81 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Lipeptides legit? See what its vials showed.
What the lab tests show
81 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | Ipamorelin | 99.7 % | 4.58 mg of 5 mg (-8 %) | Pass | View |
| Oct 12, 2026 | NAD+ | 98.1 % | 110 mg of 100 mg (10 %) | Pass | View |
| Oct 8, 2026 | NAD+ | 99.9 % | 549 mg of 500 mg (10 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 100 % | 16.5812 mg of 15 mg (11 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 100 % | 40.5422 mg of 30 mg (35 %) | Pass | View |
| Sep 25, 2026 | GHK-Cu | 98.3 % | 52.6 mg of 50 mg (5 %) | Pass | View |
| Sep 24, 2026 | BPC-157 | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 8.89 mg of 10 mg (-11 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 4.42 mg of 5 mg (-12 %) | Pass | View |
| Sep 18, 2026 | Tirzepatide | 99.99 % | 10.81 mg of 10 mg (8 %) | Pass | View |
| Sep 17, 2026 | Ipamorelin | 99.1 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Sep 17, 2026 | Retatrutide | 99.9 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| Sep 16, 2026 | BPC-157 | 95.86 % | 4.77704 mg of 5 mg (-4 %) | Pass | View |
| Sep 15, 2026 | NAD+ | 98.2 % | 488 mg of 500 mg (-2 %) | Pass | View |
| Sep 14, 2026 | Tirzepatide | 99.9 % | 62.2 mg of 60 mg (4 %) | Pass | View |
| Sep 9, 2026 | GHK-Cu | 99.9 % | 109 mg of 100 mg (9 %) | Pass | View |
| Sep 7, 2026 | Tirzepatide | 99.8 % | 46.3 mg of 40 mg (16 %) | Pass | View |
| Aug 28, 2026 | Retatrutide | 99.8 % | 29.4 mg of 30 mg (-2 %) | Pass | View |
| Aug 25, 2026 | Retatrutide | 99.8 % | 11 mg of 10 mg (10 %) | Pass | View |
| Aug 25, 2026 | Tirzepatide | 99.9 % | 31.6 mg of 30 mg (5 %) | Pass | View |
| Aug 18, 2026 | Tesamorelin | 99.6 % | 5.6 mg of 5 mg (12 %) | Pass | View |
| Aug 12, 2026 | BPC-157 | 43.6 % | 4.34 mg of 10 mg (-57 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.8 % | 23.4 mg of 20 mg (17 %) | Pass | View |
| Aug 6, 2026 | Retatrutide | 99.9 % | 31.6 mg of 30 mg (5 %) | Pass | View |
| Aug 5, 2026 | BPC-157 | 99.5 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 17.5 mg of 20 mg (-13 %) | Pass | View |
| Aug 5, 2026 | Ipamorelin | 99.8 % | 9.5 mg of 10 mg (-5 %) | Pass | View |
| Aug 4, 2026 | Retatrutide | 99.9 % | 4.94 mg of 5 mg (-1 %) | Pass | View |
| Aug 3, 2026 | KPV | 99.2 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Aug 2, 2026 | Retatrutide | 10 mg | Fail | View | |
| Aug 2, 2026 | Tirzepatide | 99.8 % | 32.8 mg of 30 mg (9 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.8 % | 42.5 mg of 40 mg (6 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.5 % | 19.5 mg of 20 mg (-3 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jul 1, 2026 | Tirzepatide | 99.9 % | 54.2 mg of 50 mg (8 %) | Pass | View |
| Jul 1, 2026 | NAD+ | 99.3 % | 808 mg of 1000 mg (-19 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 11.6 mg of 15 mg (-23 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 81.3 mg of 100 mg (-19 %) | Pass | View |
| Jun 12, 2026 | NAD+ | 96.8 % | 52.2 mg of 500 mg (-90 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 61.1 mg of 60 mg (2 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.7 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Jun 8, 2026 | BPC-157 | 98.8 % | 9.69 mg of 10 mg (-3 %) | Pass | View |
| Jun 8, 2026 | Retatrutide | 99.7 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Jun 4, 2026 | Tesamorelin | 99.3 % | 4.74 mg of 5 mg (-5 %) | Pass | View |
| Jun 2, 2026 | Retatrutide | 99.8 % | 21 mg of 15 mg (40 %) | Pass | View |
| Jun 1, 2026 | Retatrutide | 99.9 % | 18.7 mg of 20 mg (-7 %) | Pass | View |
| May 28, 2026 | Retatrutide | 99.9 % | 32.7 mg of 30 mg (9 %) | Pass | View |
| May 27, 2026 | GHK-Cu | 99.5 % | 48 mg of 50 mg (-4 %) | Pass | View |
| May 15, 2026 | TB-500 | 99.5 % | 5.7 mg of 5 mg (14 %) | Pass | View |
| May 11, 2026 | Retatrutide | 99.9 % | 15.8 mg of 15 mg (5 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 5.11 mg of 5 mg (2 %) | Pass | View |
| Apr 27, 2026 | Retatrutide | 99.8 % | 19.5 mg of 20 mg (-3 %) | Pass | View |
| Apr 22, 2026 | Retatrutide | 20 mg | View | ||
| Mar 29, 2026 | KPV | 99.7 % | 13.9 mg of 10 mg (39 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.6 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Mar 25, 2026 | Retatrutide | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Mar 18, 2026 | BPC-157 | 99.9 % | 9.83 mg of 10 mg (-2 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 4.63 mg of 5 mg (-7 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 48.1 mg of 50 mg (-4 %) | Pass | View |
| Mar 18, 2026 | TB-500 | 97.3 % | 4.71 mg of 5 mg (-6 %) | Pass | View |
What Lipeptides sells
No current listings on record.
About Lipeptides
Finnrick has tested 81 samples from Lipeptides across 9 products.